NCT07132151

Reinforcement Learned Automated Anesthesia Systems During Painless Abortion

Automated Anesthesia Systems for Painless Abortion (AAS-PA): a Multi-center, Randomized Controlled Trial

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 167 (estimated)
• Sponsor: Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd. · Industry
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This study compares the automated anesthesia systems for painless abortion (AAS-PA) with traditional anesthesia in painless abortions. It assesses intraoperative indicators (hypoxemia, injection pain, hypotension, hemodynamics, respiratory depression) and postoperative outcomes (nausea, dizziness, recovery time, satisfaction). The AAS-PA group uses AI-adjusted intravenous ciprofol based on real-time vital signs and sedation depth; the traditional group relies on manual anesthesia. The goal is to verify if AAS-PA safely manages sedation, meets painless standards, reduces adverse events, and improves experience, aiding optimized automated protocols.

Conditions

• Painless Abortion
• Artificial Intelligence (AI)
• Ciprofol

Interventions

Type	Name	Description
PROCEDURE	AI Controlled General Anesthesia	During painless abortion, anesthesia will be induced using ciprofol, and controlled by an AI model.
PROCEDURE	General Anesthesia	Anesthesia will be induced using ciprofol, and controlled by experienced anesthesiologists.

Timeline

• Start date: 2025-09-08
• Primary completion: 2025-10-08
• Completion: 2027-11-08
• First posted: 2025-08-20
• Last updated: 2025-08-20

Locations

8 sites across 1 country: China